{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:55:12Z","timestamp":1792508112988,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.radonc.2024.110269","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T22:28:28Z","timestamp":1712356108000},"page":"110269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-4693","authenticated-orcid":false,"given":"Fumiaki","family":"Isohashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-7825","authenticated-orcid":false,"given":"Ken","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0660-9987","authenticated-orcid":false,"given":"Naoya","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-1909","authenticated-orcid":false,"given":"Koji","family":"Masui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-9324","authenticated-orcid":false,"given":"Shunichi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-0035","authenticated-orcid":false,"given":"Yu","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3105-0719","authenticated-orcid":false,"given":"Yuko","family":"Kaneyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-4371","authenticated-orcid":false,"given":"Rumiko","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1654-8567","authenticated-orcid":false,"given":"Tadayuki","family":"Kotsuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Takaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6591-2743","authenticated-orcid":false,"given":"Ayaka","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110269_b0005","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2017.01.033","article-title":"Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis","volume":"145","author":"Datta","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0010","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0015","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0020","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2024.110269_b0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/MO:23:2:219","article-title":"Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico","volume":"23","author":"Ter\u00e1n-Porcayo","year":"2006","journal-title":"Med Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0030","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ygyno.2006.06.027","article-title":"Indications for primary and secondary exenterations in patients with cervical cancer","volume":"103","author":"Marnitz","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2009.09.035","article-title":"Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience","volume":"116","author":"Jurado","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/IGC.0b013e3182a80aec","article-title":"Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients","volume":"24","author":"Chiantera","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2024.110269_b0045","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","article-title":"Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer","volume":"125","author":"Schmidt","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2018.10.036","article-title":"Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies","volume":"152","author":"Tortorella","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/IGC.0b013e3181a40a8b","article-title":"Carboplatin and paclitaxel in metastatic or recurrent cervical cancer","volume":"19","author":"Pectasides","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2024.110269_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000111086","article-title":"A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix","volume":"72","author":"Benjapibal","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.radonc.2024.110269_b0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bjc.6605305","article-title":"Evaluation of the paclitaxel-ifosfamide-cisplatin (TIP) combination in relapsed and\/or metastatic cervical cancer","volume":"101","author":"Kosmas","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2024.110269_b0070","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110269_b0075","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(17)31607-0","article-title":"Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomized, controlled, open-label, phase 3 trial (gynecologic oncology group 240)","volume":"390","author":"Tewari","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110269_b0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.brachy.2020.07.007","article-title":"A national surveillance study of the current status of reirradiation using brachytherapy in Japan","volume":"20","author":"Yamazaki","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2024.110269_b0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/CCO.0000000000000392","article-title":"Re-irradiation of cervical and endometrial cancer","volume":"29","author":"Llewelyn","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clon.2017.11.013","article-title":"Re-irradiation in gynaecological malignancies: a review","volume":"30","author":"Sadozye","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2024.110269_b0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brachy.2019.11.008","article-title":"American Brachytherapy society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers","volume":"19","author":"Sturdza","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2024.110269_b0100","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/cancers13061226","article-title":"Image-guided Brachytherapy for salvage reirradiation: a systematic review","volume":"13","author":"Bockel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2024.110269_b0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IGC.0000000000000028","article-title":"Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience","volume":"24","author":"Mabuchi","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2024.110269_b0115","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.brachy.2017.07.007","article-title":"MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer","volume":"16","author":"Kamran","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2024.110269_b0120","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1200\/JCO.2012.47.9931","article-title":"Novel use of a hydrogel spacer permits reirradiation in otherwise incurable recurrent gynecologic cancers","volume":"31","author":"Viswanathan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110269_b0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5114\/jcb.2022.113549","article-title":"Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies","volume":"14","author":"Murakami","year":"2022","journal-title":"J Contemp Brachytherapy"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:39:58Z","timestamp":1741455598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024001919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":24,"alternative-id":["S0167814024001919"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110269","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110269"}}